Physician profile
Samih Ajami
NPI 1295113132
$404.07
in general payments reported to CMS, 2019-2025
9 companies · $69.58 in 2025
The $69.58 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $85.86 · 2023: $62.22 · 2024: $186 · 2025: $69.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $130.68 | 2022-2025 | Farxiga, Breztri, Seroquel |
| Exact Sciences Corporation | $67.00 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $45.57 | 2024 | Bexsero |
| Biohaven Pharmaceutical Holding Company LTD. | $39.79 | 2022 | |
| Pfizer INC. | $37.69 | 2022-2024 | |
| Lilly USA, LLC | $30.04 | 2024-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $21.82 | 2025 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $18.36 | 2024 | Veozah |
| Cranial Technologies, INC | $13.12 | 2023 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samih Ajami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.